ArticleOrphanet journal of rare diseases2014
Two years' experience with denosumab for children with osteogenesis imperfecta type VI.
Heike Hoyer-Kuhn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this papertrialcites it